28 March 2024 : Clinical Research
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
Mustafa Karaca
1ACDEF, Ece Salim2ABDEF, Mustafa Serkan Alemdar 3BDEF, Özge Deniz Karaca 2BEF, Mustafa Özgür Arıcı 3BDEF*
DOI: 10.12659/MSM.943750
Med Sci Monit 2024; 30:e943750
Table 5 Factors associated with poor pathologic response.
| Variables | OR (95% CI) | p |
|---|---|---|
| Age | 0.959 (0.932–0.988) | |
| Male gender | 1.194 (0.625–2.284) | 0.591 |
| Comorbid disease | 1.664 (0.875–3.167) | 0.121 |
| Chemotherapy agent | ||
| Capecitabine | Reference | – |
| 5-FU | 1.239 (0.663–2.317) | 0.501 |
| NLR at diagnosis >3.63 | 2.595 (1.229–5.478) | |
| OR – odds ratio; CI – confidence interval; 5-FU – 5-Fluorouracil; NLR – neutrophil/lymphocyte ratio. | ||